Diseases [C] » Neoplasms [C04] » Neoplasms by Histologic Type » Neoplasms, Connective and Soft Tissue » Sarcoma
Description
A connective tissue neoplasm formed by proliferation of mesodermal cells; it is usually highly malignant. MeSH
Hierarchy View
Subtype Terms (23)
Adenosarcoma
3 approved drugs
Carcinosarcoma
12 drugs (8 approved, 4 experimental)
Chondrosarcoma
52 drugs (35 approved, 17 experimental)
Desmoplastic Small Round Cell Tumor
35 drugs (25 approved, 10 experimental)
Endometrial Stromal Tumors
1 approved drug
Fibrosarcoma
34 drugs (24 approved, 10 experimental)
Hemangiosarcoma
31 drugs (20 approved, 11 experimental)
Histiocytoma, Malignant Fibrous
3 drugs (2 approved, 1 experimental)
Leiomyosarcoma
74 drugs (45 approved, 29 experimental)
Liposarcoma
71 drugs (41 approved, 30 experimental)
Lymphangiosarcoma
2 approved drugs
Mixed Tumor, Mesodermal
2 approved drugs
Myosarcoma
2 approved drugs
Osteosarcoma
173 drugs (98 approved, 75 experimental)
Sarcoma, Alveolar Soft Part
18 drugs (14 approved, 4 experimental)
Sarcoma, Clear Cell
33 drugs (22 approved, 11 experimental)
Sarcoma, Kaposi
73 drugs (51 approved, 22 experimental)
Sarcoma, Myeloid
35 drugs (28 approved, 7 experimental)
Sarcoma, Synovial
61 drugs (31 approved, 30 experimental)
Approved Indicated Drugs (4)
Phase 3 Indicated Drugs (56)
Phase 2 Indicated Drugs (181)
allogeneic hematopoietic stem cells (Hemacord)
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin)
disaccharide tripeptide glycerol dipalmitoyl
hydroxychloroquine (plaquenil)
Phase 1 Indicated Drugs (126)
allogeneic natural killer cells
autologous apd-l1 armored anti-cd22 car t cells
autologous cytokine induced killer cells
autologous ebv-transformed b lymphoblastoid-tumor fusion cell vaccine
autologous ny-eso-1-specific cd8-positive t lymphocytes
dec-205/ny-eso-1 fusion protein cdx-1401
F 18-fluoroazomycin arabinoside (faza)
genetically engineered ny-eso-1-specific t lymphocytes
modified vaccinia virus ankara vaccine expressing p53
nkg2dl-targetting chimeric antigen receptor-grafted gamma delta t cell
Other Experimental Indicated Drugs (15)
Organization Involved with Phase 4 Indications (18)
Organization Involved with Phase 3 Indications (107)
Children's Cancer and Leukaemia Group
Chinese Academy of Medical Sciences
Commissariat A L'energie Atomique
Connective Tissue Oncology Society
Cooperative Weichteilsarkom Study Group
Dutch Childhood Oncology Group
Eastern Cooperative Oncology Group
EBMT Solid Tumors Working Party
European Organisation for Research and Treatment of Cancer
European Paediatric Soft Tissue Sarcoma Study Group
Gesellschaft fur Padiatrische Onkologie und Hamatologie - Austria
Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany
Grupo Espanol de Investigacion en Sarcomas
Hôpital Européen Georges-Pompidou
Institut National de la Santé Et de la Recherche Médicale, France
Istituto Oncologico Veneto IRCCS
Italian Association for Pediatric Hematology Oncology
Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd
National Cancer Institute (NCI)
National Institute of Allergy and Infectious Diseases (NIAID)
People's Liberation Army of China
Polish Paediatric Solid Tumours Study Group
Sarcoma Alliance for Research through Collaboration
Societe Francaise Oncologie Pediatrique
Societe Internationale d'Oncologie Pediatrique (SIOP)
State University of New York, Buffalo
Swiss Group for Clinical Cancer Research
Swiss Pediatric Oncology Group
The Christie NHS Foundation Trust
The European Society for Hyperthermic Oncology
The Swedish Childhood Solid Tumor Working Group
Organization Involved with Phase 2 Indications (274)
Adolescent and Young Adult (AYA) Cancer Program
AIDS and Cancer Specimen Resource
Apogee Biotechnology Corporation
Arbeitsgemeinschaft fur Internistische Onkologie (AIO)
Arnold Palmer Hospital for Children
ASO SS Antonio e Biagio e C Arrigo Alessandria, Italy
Assistance Publique - Hôpitaux de Paris
Australasian Sarcoma Study Group
Autonomous University of Madrid
Bankura Sammilani Medical College
Cancer Immunotherapy Trials Network
Cancer Treatment Research Foundation
Cantonal Hospital of St. Gallen
Case Western Reserve University
Chao Family Comprehensive Cancer Center
ChemoWarrior: the eli sidler foundation
Children's National Medical Center
Christian Albrechts University
Fondazione del Piemonte IRCCS di Candiolo
Gottfried Wilhelm Leibniz Universität Hannover
Herbert Irving Comprehensive Cancer Center
Hoosier Cancer Research Network
Hospital Santa Marcelina, Sao Paulo, Brasil
Hospital Universitario Central de Asturias
Hospital Universitario Niño Jesús
Huazhong University of Science and Technology
Icahn School of Medicine at Mount Sinai
Instituto Nacional de Enfermedades Respiratorias
Istituto Clinico Humanitas - Rozzano (MI), Italy
Istituto Nazionale per lo Studio e la Cura dei Tumori
Jiangsu Cancer Institute & Hospital
Katholieke Universiteit Leuven
KK Women's and Children's Hospital
Liaoning Province Tumor Hospital
Ludwig Institute for Cancer Research
Maria Sklodowska Curie Children's Hospital
Memorial Sloan-Kettering Cancer Center
National Cancer Institute, France
National Comprehensive Cancer Network
National Institute of Cancerología
National Pediatric Cancer Foundation
National University of Singapore
Neuroblastoma and Medulloblastoma Translational Research Consortium
Oregon Health and Science University
Petrov Research Institute of Oncology
Radiation Therapy Oncology Group
Royal Liverpool & Broadgreen University Hospitals NHS Truts
Royal Marsden Hospital NHS Trust
Sarcoma Oncology Research Center, LLC
Shenzhen Geno-Immune Medical Institute
Shenzhen Hank Bioengineering Institute
Shin Kong Wu Ho-Su Memorial Hospital
The University of Texas, Dallas
Universidad Autonoma de Barcelona
Universidad Complutense de Madrid
Universitaetsklinikum Schleswig-Holstein
University of California, Davis
University of California, Los Angeles
University of Nice Sophia Antipolis
University of Western Australia
Organization Involved with Phase 1 Indications (68)
American Society of Clinical Oncology
Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna
California Institute for Regenerative Medicine
Central European Society for Anticancer Drug Research (CESAR)
Evan T.J. Dunbar Neuroblastoma Foundation
Guangdong Xiangxue Precision Medical Technology Co., Ltd
Guangdong Xiangxue Precision Medical Technology Co., Ltd.
Methodist Cancer Center, Houston, Texas
National Human Genome Research Institute (NHGRI)
New Mexico Cancer Care Alliance
Organization Involved with Other Experimental Indications (8)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
